Ingelheim, Germany - Boehringer Ingelheim today announced positive results from two global Phase III trials of its glucagon/GLP-1 dual agonist survodutide (BI 456906), SYNCHRONIZE-1 and ...

News builds on previously announced positive topline results from SYNCHRONIZE-1 76-week trial, which met its primary endpoints and showed up to 16.6% weight loss with survodutide, a novel glucagon/GLP ...

MMORPG AION: The Tower of Eternity first launched in 2008 and drew in millions of players with its magical world and its focus on flight and aerial combat. In 2018, developer NC announced it was ...

Nintendo Switch 2 owners can finally get their hands on Elden Ring on Aug. 28, publisher Bandai Namco announced Thursday. Elden Ring: Tarnished Edition will bring 2022's open-world action-RPG to ...

News builds on previously announced positive topline results from SYNCHRONIZE-1 76-week trial, which met its primary endpoints and showed up to 16.6% weight loss with survodutide, a novel glucagon/GLP ...

Zealand Pharma announces Boehringer Ingelheim's survodutide Phase III trial showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis, ...

News builds on previously announced positive topline results from SYNCHRONIZE-1 76-week trial, which met its primary endpoints and showed up to 16.6% weight loss with survodutide, a novel glucagon/GLP ...

Boehringer Ingelheim disclosed full Phase 3 data for survodutide at the American Diabetes Association's 2026 Scientific Sessions in New Orleans on Sunday, June 7, showing that nearly 1 in 5 patients ...

NEW ORLEANS — Survodutide, an investigational glucagon receptor/GLP-1 receptor dual agonist, produced significant weight loss along with reductions in visceral fat and liver fat in two phase 3 trials.

As of October 2025, the World Economic Outlook database and supporting documents will be accessible through the IMF Data portal. The World Economic Outlook (WEO) database is created during the ...

This is our single-player campaign review for Call of Duty: Modern Warfare 2. For our thoughts on PvP, check out the multiplayer review. In five years time when we discuss Call of Duty: Modern Warfare ...